GROVE COLLABORATIVE ($GROV) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of -$0.05 per share, beating estimates of -$0.09 by $0.04. The company also reported revenue of $42,410,000, missing estimates of $43,758,000 by $-1,348,000.
You can see Quiver Quantitative's $GROV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GROVE COLLABORATIVE Hedge Fund Activity
We have seen 11 institutional investors add shares of GROVE COLLABORATIVE stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 272,636 shares (-8.5%) from their portfolio in Q4 2025, for an estimated $299,899
- GSA CAPITAL PARTNERS LLP added 59,485 shares (+inf%) to their portfolio in Q4 2025, for an estimated $65,433
- JANE STREET GROUP, LLC removed 20,269 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,403
- VIRTU FINANCIAL LLC removed 18,075 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $27,112
- NORTHERN TRUST CORP added 16,053 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $17,658
- LAIRD NORTON WETHERBY TRUST COMPANY, LLC added 16,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $17,600
- CITADEL ADVISORS LLC removed 10,100 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,110
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GROVE COLLABORATIVE Analyst Ratings
Wall Street analysts have issued reports on $GROV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/11/2025
To track analyst ratings and price targets for GROVE COLLABORATIVE, check out Quiver Quantitative's $GROV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
